July 6, 2023 Multistakeholder Collaborations Are Vital to Advancing Technologies in Parkinson’s TUCSON, Ariz., July 6, 2023 — Critical Path Institute (C-Path) and the Center for Health + Technology (CHeT) at University of Ro
June 28, 2023 C-Path’s TRxA Announces $750,000 in Research Awards to Accelerate its First Drug Development Projects TUCSON, Ariz., June 28, 2023 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) announced toda
June 25, 2023-June 29, 2023 DIA 2023 Global Annual Meeting | ILLUMINATE The DIA 2023 Global Annual Meeting invites industry, regulatory government, academics, and patients to network, problem-solve, and
June 21, 2023-June 24, 2023 2023 Critical Care Congress January 21-24, 2023 Moscone Center South in San Francisco, California Explore the latest knowledge and research in critical care a
June 20, 2023 C-Path’s Integrated Clinical Trial Database to Help Advance Research in Parkinson’s TUCSON, Ariz., June 20, 2023 — Critical Path Institute (C-Path), an independent nonprofit organization, today announced it is pr
June 15, 2023 US and UK policy responses to the challenges of repurposing approved drugs for new indications
June 14, 2023-February 8, 2024 CeBil Symposium The CeBil symposium marks the conclusion of the Novo Nordisk Foundation’s Collaborative Research Program in Biomedical Innovatio
June 13, 2023 C-Path’s PSTC Receives Positive FDA Response for Drug-Induced Pancreatic Injury Biomarkers Safety biomarkers aim to provide an additional tool for detecting acute drug-induced pancreatic injury (DIPI) in phase 1 clinical
June 12, 2023 Fosfomycin for Non-Urinary Tract Infections: a systematic review Although fosfomycin is currently approved for treating urinary tract infections, it is increasingly being used as salvage...
